Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina

Olivier Muller1, Michalis Hamilos, Jozef Bartunek

  • 1Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium.

Insights

Impaired endothelial function in patients with stable angina is linked to higher platelet reactivity after clopidogrel treatment. This association may predict unfavorable outcomes following percutaneous coronary intervention (PCI).

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Pharmacology

Background:

  • Platelet reactivity is elevated in stable angina patients with extensive atherosclerosis.
  • Peripheral microcirculatory endothelial dysfunction may correlate with post-clopidogrel platelet reactivity.
  • This correlation could predispose patients to adverse outcomes after percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To evaluate the correlation between peripheral microcirculatory endothelial function and platelet reactivity after clopidogrel administration.
  • To determine if impaired endothelial function predicts unfavorable outcomes in patients undergoing elective PCI.

Main Methods:

  • Assessed endothelial function using peripheral arterial tonometry (Endoscore) and von Willebrandt factor levels in 52 stable angina patients undergoing PCI.
  • Measured basal platelet reactivity via soluble P-selectin.
  • Assessed platelet reactivity post-clopidogrel loading dose using VerifyNow P2Y12 assay (P2Y12 reaction unit and % inhibition).

Main Results:

  • Impaired endothelial function (lower Endoscore) correlated with increased platelet reactivity (higher soluble P-selectin and P2Y12 reaction unit).
  • Endothelial function inversely correlated with von Willebrandt factor activity.
  • Patients with elevated troponin T post-PCI had significantly lower Endoscores, indicating impaired endothelial function.

Conclusions:

  • Impaired endothelial response before clopidogrel treatment is associated with greater residual platelet reactivity after treatment.
  • This association may explain unfavorable PCI outcomes in patients with more severe endothelial impairment.
  • Endothelial function assessment could aid in stratifying PCI risk.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...